The S387Y mutation of the transforming growth factor-β receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3363-3364

  Anbazhagan, Ramaswamy ^a   Bornman, Daniel M ^a   Johnston, James C ^a   Westra, William H ^a   Gabrielson, Edward ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR; ACTIVIN RECEPTOR 1; DNA; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CLINICAL ARTICLE; DISEASE ASSOCIATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; ADENOCARCINOMA; BREAST TUMOR; CLASSIFICATION; COLORECTAL TUMOR; FEMALE; GENETICS; LUNG TUMOR; MALE; METASTASIS; PATHOLOGY; POINT MUTATION; STRUCTURE ACTIVITY RELATION;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033564973     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bevilacqua, G., Sobel, M. D., Liotta, L. A., and Steeg, P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49: 5185-5190, 1989.
2. Fidler, I. J., and Radinsky, R. Search for genes that suppress cancer metastasis. J. Natl. Cancer Inst., 88: 1700-1703, 1996.
3. Chen, T., Carter, D., Garrigue-Antar, L., and Reiss, M. Transforming growth factor β type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res., 58: 4805-4810, 1998.
4. Fujii, H., Marsh, C., Cairns, P., Sidransky, D., and Gabrielson, E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res., 56: 1493-1497, 1996.
5. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol., 25: 705-713, 1989.
6. Reiss, M., and Barcellos-Hoff, M. H. Transforming growth factor-β in breast cancer a working hypothesis. Breast Cancer Res. Treat., 45: 81-95, 1997.
7. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
8. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L. Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-352, 1996.
9. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
10. Kalkhoven, E., Roelen, B. A., de Winter, J. P., Mummery, C. L., van den Eijnden-van Raaij, A. J., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ., 6: 1151-1161, 1995.
11. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
12. de Winter, J. P., Roelen, B. A., ten Dijke, P., van der Burg, B., and van den Eijnden-van Raaij, A. J. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumor cells. Oncogene, 14: 1891-1899, 1997.
13. Riggins, G. J., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
14. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
15. Yokota, T., Matsumoto, S., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn. J. Cancer Res., 88: 959-964, 1997.